# Endovascular Denervation (EDN) for the Treatment of Type 2 Diabetes Mellitus

> **NCT05673668** · NA · UNKNOWN · sponsor: **Zhongda Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Type 2 Diabetes Mellitus (T2DM)

## Interventions

- **DEVICE:** Endovascular Denervation System (Netrod)

## Key facts

- **NCT ID:** NCT05673668
- **Lead sponsor:** Zhongda Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-12-27
- **Primary completion:** 2023-10-30
- **Final completion:** 2024-04-30
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2023-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05673668

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05673668, "Endovascular Denervation (EDN) for the Treatment of Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05673668. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*